Encompass Health Stock (NYSE:EHC), Analyst Ratings, Price Targets, Predictions

The latest price target for Encompass Health (NYSE: EHC) was reported by Raymond James on April 26, 2024. The analyst firm set a price target for $95.00 expecting EHC to rise to within 12 months (a possible 9.99% upside). 19 analyst firms have reported ratings in the last year.

The latest analyst rating for Encompass Health (NYSE: EHC) was provided by Raymond James, and Encompass Health reiterated their strong buy rating.

The last upgrade for Encompass Health Corp happened on August 2, 2021 when Raymond James raised their price target to $107. Raymond James previously had an outperform for Encompass Health Corp.

There is no last downgrade for Encompass Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Encompass Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Encompass Health was filed on April 26, 2024 so you should expect the next rating to be made available sometime around April 26, 2025.

While ratings are subjective and will change, the latest Encompass Health (EHC) rating was a reiterated with a price target of $85.00 to $95.00. The current price Encompass Health (EHC) is trading at is $86.37, which is within the analyst’s predicted range.